Synapse - Arielle Elkrief

Results (43)

Gene copy deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic features and association with the outcomes of immunotherapy with or without chemotherapy in nonsquamous NSCLC

Journal Article

Gandhi, M. M.; Elkrief, A.; Moore, C. G.; Ricciuti, B.; Alessi, J. V.; Richards, A. L.; Tischfield, S.; Williams, J.; Lamberti, G.; Pecci, F.; more...
Journal of Thoracic Oncology (2025)

Fulltext@MSK | Save

Factors associated with disease progression after discontinuation of immune checkpoint inhibitors for immune-related toxicity in patients with advanced non-small cell lung cancer

Journal Article

Pecci, F.; Thummalapalli, R.; Alden, S. L.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Rizvi, H.; Wang, X.; Jeng, M.; Egger, J. V.; more...
Clinical Cancer Research (2025)

Fulltext@MSK | Save

Tumor immunophenotypic correlates in patients aged 80 years or older with non-small cell lung cancer and outcomes to first-line pembrolizumab in PD-L1 high (≥50%) patients

Journal Article

Barrichello, A. P. C.; Elkrief, A.; Ricciuti, B.; Ganta, T.; Marron, T. U.; Wang, X.; Lotter, W.; Lindsay, J.; Santo, V.; Cortellini, A.; more...
Clinical Lung Cancer (2025)

Fulltext@MSK | Save

Pan-cancer analysis of biallelic inactivation in tumor suppressor genes identifies KEAP1 zygosity as a predictive biomarker in lung cancer

Journal Article

Zucker, M.; Perry, M. A.; Gould, S. I.; Elkrief, A.; Safonov, A.; Thummalapalli, R.; Mehine, M.; Chakravarty, D.; Brannon, A. R.; Ladanyi, M.; more...
Cell (2025)

Fulltext@MSK | Save

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors

Journal Article

Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; more...
Annals of Oncology (2025)

Fulltext@MSK | Save

Clinical activity of mitogen-activated protein kinase inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers

Review

Dankner, M.; Rousselle, E.; Petrecca, S.; Fabi, F.; Nowakowski, A.; Lazaratos, A. M.; Vincent Rajadurai, C.; Stein, A. J. B.; Bian, D.; Tai, P.; more...
JCO Precision Oncology (2025)

Fulltext@MSK | Save

Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis

Journal Article

Shang, J.; Del Valle, D. M.; Britton, G. J.; Mead, K. R.; Rajpal, U.; Chen-Liaw, A.; Mogno, I.; Li, Z.; Menon, R.; Gonzalez-Kozlova, E.; more...
Journal of Experimental Medicine (2025)

Fulltext@MSK | Save

Clinical outcomes and immunotherapy retreatment in patients with metastatic NSCLC who complete at least two years of immune checkpoint blockade

Meeting Abstract

Ricciuti, B.; Hong, L.; Gariazzo, E.; Gorria, T.; Thummalapalli, R.; Awosika, N.; Mollica, L.; Citarella, F.; Gandhi, M.; Elkrief, A.; more...
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Genomic correlates of response to chemoimmunotherapy in STK11MUT and KEAP1MUT metastatic non-small cell lung cancer

Meeting Abstract

Saini, A.; Elkrief, A.; Hong, L.; Ricciuti, B.; Garbo, E.; Pecci, F.; Makarem, M.; Di Federico, A.; Gandhi, M. M.; Aldea, M.; more...
Journal of Thoracic Oncology (2024)

Fulltext@MSK | Save

Response to crizotinib after entrectinib resistance in ROS1-rearranged, MET-amplified lung adenocarcinoma

Journal Article

Vaz, V. R.; Gandhi, M. M.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Ladanyi, M.; Vanderbilt, C.; Pecci, F.; Aldea, M.; Barrichello, A.; more...
JCO Precision Oncology (2024)

Fulltext@MSK | Save